InvestorsHub Logo
Followers 33
Posts 5288
Boards Moderated 0
Alias Born 01/23/2019

Re: rosemountbomber post# 301463

Friday, 09/25/2020 10:31:52 AM

Friday, September 25, 2020 10:31:52 AM

Post# of 425796
rosemount, it's plausible that amarin could capture the FDA approved EPA market, if they went AG with vascepa then acquired the license for DS 102 epeleuton, less aggravation with the generics suing them for their patents. I believe margins would be higher with a synthetic FDA approved EPA. It's a consideration given the similar background of the management from Elan i.e. Dr. Lars Ekman, Dr. Climax et al then and now Dr. Bhatt. You never know!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News